What is ALCOHOL 5% AND DEXTROSE 5% used for?

ALCOHOL 5% AND DEXTROSE 5% is an FDA-approved medication. See full prescribing information for approved uses.

Is ALCOHOL 5% AND DEXTROSE 5% FDA approved?

Yes, ALCOHOL 5% AND DEXTROSE 5% is FDA approved (first approved 1946-01-17) and manufactured by B BRAUN.

Who makes ALCOHOL 5% AND DEXTROSE 5%?

ALCOHOL 5% AND DEXTROSE 5% is manufactured by B BRAUN.

Data updated: Jun 28, 2026

ALCOHOL 5% AND DEXTROSE 5% (alcohol) · B BRAUN

Other Approved 1946-01-17

Jump to: Indications Approvals Trials Competitors Safety Patents

Indication

Phase 3 Trials

Years on Market

Details

Status: Discontinued
First Approved: 1946-01-17
Routes: INJECTION
Dosage Forms: INJECTABLE

Companies

B BRAUN

Active Ingredient: ALCOHOL , DEXTROSE

ALCOHOL 5% AND DEXTROSE 5% Approval History

1947

1948

1949

1950

1951

1952

1953

1954

1955

1956

1957

1958

1959

1960

1961

1962

1963

1964

1965

1966

1967

1968

1969

1970

1971

1972

1973

1974

1975

1976

1977

1978

1979

1980

1981

1982

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Original

New Indication

New Form

Label Update

10 FDA actions from 1946 to 1985

Oct 1985 SUPPL

Label · Labeling

Jun 1985 SUPPL

Mfg · Manufacturing (CMC)

Jul 1984 SUPPL

Mfg · Manufacturing (CMC)

Unlock 6 earlier FDA actions Pro

What ALCOHOL 5% AND DEXTROSE 5% Treats

1 FDA approvals

Originally approved for its first indication in 1946 .

Other (1)

📋

Clinical Trial Registry

22 trials

Trial	Sponsor ID	Phase	Status	Title
NCT00713492	080178 08-AA-0178	Ph 1	completed	Computer-Assisted Self-Administration of Ethanol
NCT04300751 results posted	55176 R01DA016718	Ph 1	completed	The Behavioral Effects of Opioids and Alcohol
NCT04931095	IRB00290015 1R01DA052295-01	Ph 1	completed	The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT06293040	IRB00434441 R01DA052295	Ph 1	recruiting	Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT00295334 results posted	250505	Ph 2	completed	Moderate Alcohol Intake Among Patients With Type 2 Diabetes
NCT06712602	90580 R01AA030774	Ph 1	recruiting	PT150 Drug for Use in Alcohol Use Disorder
NCT03503773 results posted	CR0014	Ph 2	completed	The TARGET BP OFF-MED Trial
NCT03575403 BED[IN]:36 results posted	44796 R01AA026255	Ph 1	completed	Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)
NCT04003402	8062-CL-2001	Ph 1	completed	A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects
NCT05389930	2022003195 R01AA029711	Ph 2	recruiting	Cannabis' Impact on Alcohol Consumption
NCT03699540 results posted	43636 R21DA045101-02	Ph 1	completed	Marijuana Effects on Simulated Driving Performance
NCT06524609	EGCG-TIPN	Ph 1, Ph 2	recruiting	EGCG for the Prevention and Treatment of TIPN
NCT05273658	192048	Ph 1, Ph 2	withdrawn	Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests
NCT00559819 ALCDrive	MMoric111207	Ph 3	completed	Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
NCT03416348	OP150030 (Aim 1&2) OP150030	Ph 1	completed	Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2
NCT03361384	14-068 R01AA022301	Ph 1	completed	Alcohol and Implicit Process in Sexual Risk Behavior in MSM
NCT03483636	E2006-A001-009	Ph 1	completed	Study of Lemborexant-Alcohol Interaction in Healthy Subjects
NCT02046200 results posted	IVM UL1TR000124	Ph 1, Ph 2	completed	Development of Ivermectin for Alcohol Use Disorders
NCT01779024 results posted	130043 13-AA-0043	Ph 2	completed	Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers
NCT02488889 VAR	23FT-0102	Ph 4	withdrawn	Effects of Varenicline in Heavy Drinking Smokers
NCT02294266	IMIMFTCL/MEF/2	Ph 1	completed	Mephedrone and Alcohol Interactions in Humans
NCT00879047	R01AA018001	Ph 1	completed	Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

| Show all trials (incl. adjuvant)

Understanding FDA Approval Types

Count	Type	What it means
-	ORIG	Original approval - drug first enters market
-	SUPPL - Efficacy	New indication (new disease/condition approved)
-	SUPPL - Labeling	Label text changes (warnings, dosing updates)
-	SUPPL - Manufacturing	Production changes (new facility)
-	SUPPL - Chemistry	Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ALCOHOL 5% AND DEXTROSE 5% FDA Label Details

Track ALCOHOL 5% AND DEXTROSE 5% with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

FDA Approval: NDA004589 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.